Leadership Team

Lisa Rich-Milan


Lisa was appointed Chief Executive Officer of Caligor Coghlan Pharma Services on June 25, 2018, and she also serves on the Caligor Coghlan Pharma Services’ Board of Directors. She is responsible for leading the growth of Caligor Coghlan Pharma Services’ Clinical Supply Services and Global Pre- Approval Access Services.


Lisa has over 30+ years of experience as an Executive in pharmaceuticals, biotech, generics, and diagnostics industries. Prior to assuming the role of CEO with Caligor Coghlan Pharma Services, Lisa served as the CEO of CompuNet Clinical Laboratories, a Quest Diagnostics Joint Venture for laboratory services, leading over 635 employees with responsibilities for driving company strategy and ensuring achievement of growth targets, operation efficiencies, and new market branding through new alternative sales channels. She also led the commercial teams for Quest Diagnostics Clinical Informatics nationally. Prior to Quest Diagnostics, Lisa was the GM over North America at Synthon Pharmaceuticals, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generics. Throughout her career, Lisa has held C-suite and sales and marketing executive leadership roles leading clinical trials commercial teams, alliance partnerships, sales, marketing, operations, quality, medical, and payer teams across the U.S. and internationally.

Lisa holds a bachelor’s degree in Business Administration, with emphasis on Finance/Accounting from the University of Dayton, Dayton Ohio.

Terry Coghlan

EVP, Packaging and Labeling
Terry is the EVP of Packaging and Labeling at Caligor Coghlan Pharma Services where he manages the growth and strategic vision of that division. Prior to the acquisition, Terry founded The Coghlan Group, Inc. and served as its Chairman, President and Chief Executive Officer, from 1996 until 2017.
Prior to founding The Coghlan Group, Terry established the Clinical Supplies Division at Pharmaco, which merged with PPD of Wilmington, NC to form PPD Pharmaco, one of the largest clinical contract research organizations in the world. Terry was responsible for the US and Belgium clinical supply facilities. During his early years at Pharmaco, Terry held the positions of Sr. Clinical Scientist and Project Manager before taking on the clinical supplies division responsibilities in 1989.

Kerry Myers

VP, Commercial

Kerry joined Caligor Coghlan Pharma Services as Vice President of Commercial in August 2018. She is responsible for leading Caligor Coghlan Pharma Services’ global sales and marketing efforts.

Kerry has more than fifteen years of success designing, launching, marketing, and selling solutions in the healthcare industry. Prior to joining Caligor Coghlan Pharma Services, Kerry spent seven years at Quest Diagnostics, a market leader in diagnostic services. There she served as the Business Leader for Quest Diagnostics’ Payer Analytics Portfolio, where she was responsible for developing the product pipeline, building the go-to-market strategy, and leading marketing and commercialization efforts. Kerry began her career in sales and marketing with Pfizer and held roles of increasing responsibility at various pharmaceutical and healthcare equipment companies.

Kerry holds a bachelor’s degree in statistics and certification in actuarial science from Florida State University.

Angel Gonzalez

VP, Global Operations and Clinical Supply Chain

Angel joined Caligor Coghlan Pharma Services as Global Vice President of Supply Chain in February 2018. He is responsible for leading Caligor Coghlan Pharma Services’ global operations and end to end supply chain.


Angel has more than 30 years of success designing and leading supply chains in the healthcare industry in areas including devices and pharmaceutical products manufacturing. Prior to joining Caligor Coghlan Pharma Services, Angel spent 20 years at Johnson and Johnson, a global leader in health care where he led pharmaceutical and device manufacturing sites. His most recent role with Johnson and Johnson was developing supply chain strategic plans for the device sector. In his years at Johnson and Johnson, Angel had the opportunity to successfully lead the McNeil pharmaceutical consent decree remediation plans. Prior to that, Angel spent 15 years at Hoffmann-La Roche, where he served as the Manufacturing Leader of the solids, liquids, and sterile manufacturing departments. Angel started his career as an Industrial Engineer, where concentrated in developing continuous improvement processes and cost reduction programs.

Angel holds a bachelor’s degree in Industrial Engineering, a MS in Finance, and an MBA in Management of Technology, all from the New Jersey Institute of Technology.

Mike Butterworth

VP, Packaging and Labeling


Mike is the VP of Packaging and Labeling at Caligor Coghlan Pharma Services. Mike leads the global project management team responsible for all tasks associated with packaging, labeling, distribution and drug supply management for Caligor Coghlan Pharma Services. In addition, he serves as the company’s subject matter expert for packaging and labeling operations.


Since joining the company in 2008, Mike has held positions of increasing responsibility. Prior to moving into the VP of Packaging and Labeling role, he served as the Global Director of Operations for the company where he was responsible for managing Caligor Coghlan Pharma Services’ expansive depot and supplier network.

Mike holds a bachelor’s degree in Physics from Gustavus Adolphus College, and a MBA from the University of Texas.

Geoff Fatzinger

Global VP, Regulatory Affairs


Geoff joined Caligor Coghlan Pharma Services as Global Vice President of Regulatory in June 2019. He is responsible for leading Caligor Coghlan Pharma Services’ global Regulatory and Quality teams.


Geoff is a highly experienced, results-oriented global regulatory professional, with very strong strategic capabilities and a very solid technical background that has allowed him to lead companies and projects to new levels of success in a variety of highly competitive industries, cutting-edge markets, and fast-paced environments.

Geoff brings 20+ years of expertise and a demonstrated record of regulatory and business accomplishments covering the United States, Europe, Asia Pacific (with in depth experience in Japan, China, and Korea), and Middle East having lived and worked in many countries championing regulatory affairs.

His proven abilities in the successful creation and implementation of global regulatory strategies from concept to commercialization, business planning, global growth strategies, in-licensing and commercial valuations has helped numerous companies reach their business objectives on a global scale.

He has been directly involved in all phases of product development globally. His specialties include global and product regulatory strategy development; market assessments; agency interactions; HEOR and Regulatory Economics; extensive global experience in drug and device development; clinical trials, and approvals, including such areas as: biosimilar development and approval; nanotechnology, stem cell and gene therapy products, medical devices; in-licensing and divestitures; and regulatory due diligence.

Geoff is a frequent lecturer on international regulatory affairs and regulatory law, as well as a contributing member to several organizations including TOPRA and lecturer at Cranfield for the Regulatory Affairs education programs.

Lynn Waltzman

Senior Global Operations Director, Expanded Access Programs


Lynn joined Caligor Coghlan Pharma Services in March 2018, and she was promoted into her current role in December 2018. She is responsible for leading operations for Caligor Coghlan Pharma Services’ Pre-Approval Access Programs including managing the Program Management team.


Lynn has over 24 years of Clinical Operations and Clinical Supply experience, including the set-up, launch and oversight of Expanded Access Programs. Lynn has held positions of increasing responsibility in small biotech and mid-size pharmaceutical companies and her development experience spans several therapeutic areas from post-operative pain, CNS, GI and oncology. Lynn began her career as a Quality Assurance Coordinator working for a Site Management Organization. From there, Lynn transitioned into Clinical Operations and worked at Regeneron Pharmaceuticals, Purdue Pharma and Javelin Pharmaceuticals. To gain a fuller appreciation of other aspects within R&D, Lynn shifted her focus to Clinical Supply and began working as a Program Director at Fisher Clinical Services, where she supported small biotech and large pharmaceutical companies by providing strategic oversight and forecasting for their clinical packaging and distribution needs. Lynn then moved back over to the Sponsor-side providing global Clinical Supply oversight at Immunogen, Karyopharm and Alkermes.

Lynn graduated from Skidmore College with a bachelor’s degree in Political Science and went on to earn her MBA at Baruch College, The City University of New York.

David Konteh

Director of Commercial Excellence
David Konteh joined Caligor Coghlan Pharma Services as the Director of Commercial Excellence in 2018. He is responsible for leading special projects that help drive growth within the company.

David has more than 20 years of corporate finance experience where he has built a vast network of experience in the life sciences, finance and technology industries, as well as with family and minority owned businesses. He is an expert in brand and generic pharmaceuticals, and he has influenced the decision-making process of fortune 500 companies in raising over $500 million in public and private capital for several pharmaceutical, insurance, and technology companies. His career highlights prior to joining Caligor Coghlan Pharma Services include Associate Director of Decision Support and Predictive Analytics at CompuNet Clinical Labs, Director of Strategic Sourcing at Novartis Pharmaceutical, Director of Finance, Genworth Financials, Strategic Analyst at MetLife insurance, Strategic Analyst at IBM, Analyst at Thomson Reuters and few other companies nationally and internationally.

David holds a master’s degree from Webster University and a PhD from Oxford, and he is fluent in several languages including English, French, Dutch, and German.

Diana Turgeon

HR Manager


Diana joined Caligor Coghlan Pharma Services as Human Resources Manager in January 2016. She is responsible for leading all aspects of Caligor Coghlan Pharma Services’ U.S. human resources, working closely with her counterpart in the UK.

Diana has more than twenty years of experience providing strategic planning, staffing, employee relations, compliance and organization development. Prior to joining Caligor Coghlan Pharma Services, Diana spent the past five years providing human resource consulting services to multiple mid-sized businesses following an eighteen year tenure at Rand McNally.

Diana holds a bachelor’s degree in English/Psychology from Northern Illinois University and a master’s degree in Health Services Administration from the University of Illinois.


HR Manager


Lauren joined Caligor Coghlan Pharma Services as Human Resources Manager in February 2018. She is responsible for leading all aspects of Caligor Coghlan Pharma Services’ U.K. human resources and working closely with her counterpart in the US.

Lauren has more than fifteen years of experience assisting with strategic planning, staffing, employee relations, compliance and organization development. Prior to joining Caligor Coghlan Pharma Services, Lauren spent seventeen years working in human resources within a Further Education College.

Lauren holds qualifications in Human Resources and Administration.




Packaging and Labeling

Global Storage & Distribution

Clinical Returns and Destruction



Our support and oversight of Pre-Approval Access Programs enables patients to receive life-improving medications faster.


At Caligor Coghlan Pharma Services, we apply our expertise to ensure your success. Whether it is for a clinical trial or a pre-approval access program, our goal is simple: to help you provide patients with faster access to relief. We create strategic solutions to help you bring your products to market in an efficient and cost-effective manner, demonstrating consistent dedication to quality assurance and regulatory compliance along every step of the way.